ArticleTranslational cancer research2023

PD-L1 expression on tumor cells as a potential predictive biomarker for patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy followed by durvalumab.

Lukas Käsmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.